U

investors

With a rapidly growing business in Europe and plans for a future launch in the US, Sedana Medical is well-positioned for the future.

We are well on the way to our vision of making inhaled sedation a standard therapy in critical care.

The Share

See More

Press Releases

2026

Invitation to presentation of Sedana Medical’s interim report for the second quarter 2026
2026-07-03 13:00
Sedana Medical AB (publ) plans to present its interim report for the second quarter of 2026 on Friday July 17 at 13:30 CET. According to the financial...
Mikael Haag takes office as new CFO of Sedana Medical
2026-06-17 08:00
Regulatory
Sedana Medical AB (publ) today announces that Mikael Haag takes office as Chief Financial Officer (CFO) and member of the Executive Management Team, effective...
Sedana Medical submits New Drug Application to the U.S. FDA for inhaled sedation in the ICU
2026-06-17 07:30
Sedana Medical AB (publ) today announces that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the drug-device...
View All Press Releases

Financial Reports

See More

Financial Calendar

See More

Latest Presentation

No presentations found.

See More